Impact of Adding Concomitant Chemotherapy to Hyperfractionated Accelerated Radiotherapy for Advanced Head-and-Neck Squamous Cell Carcinoma

This publication has 31 references indexed in Scilit:

• Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancer
  Head & Neck, 2007
• Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
  The Lancet, 2006
• Concomitant chemotherapy and radiation therapy certainly improves local control
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
• Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial
  The Lancet, 2003
• Radiotherapy for cancer of the head and neck: altered fractionation regimens
  The Lancet Oncology, 2002
• Head and Neck Cancer
  New England Journal of Medicine, 2001
• Estimating the world cancer burden: Globocan 2000
  International Journal of Cancer, 2001
• A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
• Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial
  Radiotherapy and Oncology, 1997
• The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects
  Radiotherapy and Oncology, 1995